Asta Medica Aktiengesellschaft
Records under this name other than patents Asta Medica Aktiengesellschaft holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Asta Medica Aktiengesellschaft
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,538,151 | Modifications of 2-amino-4-(4-fluorobenzylamino)-1-ethoxycarbonylaminobenzene, and processes for their preparation Formerly held Term ended Term ended Dec 6, 2023 · USPTO record | Term ended | Term ended Dec 6, 2023 | USPTO record |
| US 6,667,058 | Oral forms of administration containing solid flupirtine with controlled release of active substance Formerly held Term ended Term ended Nov 25, 2022 · USPTO record | Term ended | Term ended Nov 25, 2022 | USPTO record |
| US 6,828,415 | Oligopeptide lyophilisate, their preparation and use Formerly held Term ended Term ended Dec 7, 2021 · USPTO record | Term ended | Term ended Dec 7, 2021 | USPTO record |
| US 8,820,321 | Storage System for Powdered Pharmaceuticals, and Inhaler Equipped with This System Formerly held Term ended Term ended Jul 10, 2021 · Medium confidence | Term ended | Term ended Jul 10, 2021 | Medium confidence |
| US 6,436,924 | Antihistamine leukotriene combinations Formerly held Term ended Term ended Feb 15, 2021 · USPTO record | Term ended | Term ended Feb 15, 2021 | USPTO record |
| US 7,234,464 | Storage system for powdered pharmaceuticals, and inhaler equipped with this system Formerly held Term ended Term ended Dec 18, 2020 · USPTO record | Term ended | Term ended Dec 18, 2020 | USPTO record |
| US 6,545,039 | Facilitated administration of &agr;-lipoic acid or derivatives thereof Formerly held Term ended Term ended Nov 9, 2020 · USPTO record | Term ended | Term ended Nov 9, 2020 | USPTO record |
| US 6,251,935 | Treatment of migraine by administration of .alpha.-lipoic acid or derivatives thereof Formerly held Term ended Term ended Aug 15, 2020 · USPTO record | Term ended | Term ended Aug 15, 2020 | USPTO record |
| US 6,630,157 | Therapeutic and dietary compositions containing essential fatty acids and bioactive disulphides Formerly held Term ended Term ended Aug 15, 2020 · USPTO record | Term ended | Term ended Aug 15, 2020 | USPTO record |
| US 6,627,609 | LHRH antagonists having improved solubility properties Formerly held Term ended Term ended Mar 14, 2020 · USPTO record | Term ended | Term ended Mar 14, 2020 | USPTO record |